Knowing the kind of receptor on the cell for which the medicine will be targeted and using cell-specific ligands will enable the nanoparticle to attach exclusively to the cell that has the corresponding receptor. Cellular targeting is one method to actively target just sick tissue in the body. Intracellular delivery, a long-researched area in contemporary biotechnology, allows for effective medication administration into a variety of cell types. It is a crucial step in several cellular-level investigations, including gene delivery for gene editing and a number of biological research applications.
a. Targeted Drug Delivery System: A targeted drug delivery system is a specialised type of medication administration in which the drug is only delivered at the site of action and not to the target organs, tissues, or cells.
b. Drug Targeting and Design: The capacity of a drug to acquire in the target tissue or organ particularly, so that the concentration of drug will be high at the illness, while its concentration is low in non-target organs and tissues, preferably below the certain minimal level to prevent any toxic effects, is referred to as drug targeting.
The non-specific harmful impact of traditional medication administration can be reduced using drug targeting. Another name for drug design is rational drug design or just rational design.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada